Shopping Cart

No products in the cart.

AGENDA

Day 2: Symposium #2 – Radio City Hall

Digital Biomarkers in Cancer Care: Advancing Outcomes Through Integrated Patient Monitoring

Get Pass
Sponsor

9:30 AM

Explore the disruptive technologies, biotech breakthroughs, and data-driven models—such as digital biomarkers and real-time monitoring—that are reshaping oncology from lab to bedside.

Daniel Schneider, Director, Global Precision Medicine Strategy, Hematology, Johnson & Johnson

10:00 AM

A deep dive into structural inequities in research and care delivery, including how digital biomarkers and decentralized monitoring can expand access and improve representation.

Representative of Abbvie

10:35 AM

Networking BREAK

11:00 AM

Explore how integrating digital biomarkers and remote data collection can make clinical trials more inclusive, scalable, and reflective of diverse patient populations.

Dr. Larry Norton, Senior VP, Office of the Hospital President, Memorial Sloan Kettering Cancer Center

11:30 AM

Discover how patient-centric innovations—from wearable biomarker tracking to remote symptom monitoring—are personalizing cancer care and enhancing the patient experience.

Alexia Priest, Director, Business Development, HITLAB

Abhilasha Ramasamy, Executive Director and Head, HEOR Evidence Strategy and Synthesis, Novo Nordisk 

12:00 PM

An interactive session exploring how digital health tools, including digital biomarkers, are accelerating global access to cancer innovation, care coordination, and monitoring.

Prem Sreenivasan, Senior Fellow, HITLAB

12:30 PM

LUNCH

1:30 PM

Insight into funding trends for digital biomarker platforms, personalized diagnostics, and integrated monitoring solutions that are redefining the oncology innovation pipeline.

John Hammitt, Global Executive Director, HITLAB

2:00 PM

Case studies on how cross-sector partnerships are advancing digital biomarker development, MRD tracking, and the deployment of personalized cancer therapeutics.

Stan Kachnowski, Chair, HITLAB

2:30 PM

NETWORKING BREAK

3:00 PM

Explore how AI-driven insights, combined with digital biomarker data, are enabling real-time decision-making, early detection, and personalized treatment strategies in oncology.

Amy West, Principal, Advisory Services & Chair Women’s Global Health Tech Initiative, HITLAB

3:30 PM

Highlighting the role of digital biomarkers, remote monitoring, and AI-enabled trial models in addressing rare cancers and underserved patient populations.

Alexia Priest, Director, Business Development, HITLAB

Report

Harassment or bullying behavior
Contains mature or sensitive content
Contains misleading or false information
Contains abusive or derogatory content
Contains spam, fake content or potential malware

Block Member?

Please confirm you want to block this member.

You will no longer be able to:

  • See blocked member's posts
  • Mention this member in posts
  • Invite this member to groups
  • Message this member
  • Add this member as a connection

Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.

Report

You have already reported this .